Shared decision making in antipsychotic management

Journal of Psychiatric Practice

Volumn 14, Issue 6, 2008, Pages 333-344

  Mistler, Lisa A ^a,b,c   Drake, Robert E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Antipsychotic agents; Decision making; Evidence based medicine; Patient preference; Treatment guidelines

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

CLINICAL DECISION MAKING; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG WITHDRAWAL; ECONOMIC ASPECT; HUMAN; HYPERGLYCEMIA; MEDICAL ETHICS; MENTAL HEALTH CARE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRESCRIPTION; PSYCHIATRIST; REVIEW; SCHIZOPHRENIA; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; TARDIVE DYSKINESIA; UNITED STATES; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; ARTICLE; DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN RELATION; METHODOLOGY; PATIENT ADVOCACY; PRACTICE GUIDELINE; PSYCHOSIS;

ANTIPSYCHOTIC AGENTS; CHOICE BEHAVIOR; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT ADVOCACY; PATIENT CARE TEAM; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL-PATIENT RELATIONS; PSYCHOTIC DISORDERS;

EID: 59649105496     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000341889.97759.54     Document Type: Review

References (123)

1. Washington, DC, Committee on Quality of Health Care in America. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: Institute of Medicine, National Academies Press; 2001 (available at www.iom.edu/CMS/8089/5432.aspx, accessed October 14, 2008).
2. Washington, DC, Committee on Quality of Health Care In America. Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: Institute of Medicine, National Academies Press; 2006 (available at www.iom.edu/CMS/3809/19405/30836.aspx, accessed October 14, 2008).
3. President's New Freedom Commission on Mental Health. Achieving the Promise: Transforming mental health care in America. Rockville, MD: DHHS Pub. No. SMA-03-3832; final report 2003 (available at www.mentalhealthcommission.gov/ reports/reports.htm, accessed October 14, 2008).
4. Turner JC, TenHoor WJ. The NIMH community support program: Pilot approach to a needed social reform. Schizophr Bull 1978;4:319-48.
5. Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 2006;67:3-8.
6. Lehman AF, Kreyenbuhl J, Buchanan RW, et al. The schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophr Bull 2004; 30:193-217.
7. Glick ID, Suppes T, DeBattista C, et al. Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia. Ann Intern Med 2001;134:47-60.
8. Glick ID, Murray SR, Vasudevan P, et al. Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res 2001;35:187-91.
9. Wyatt RJ. Research in schizophrenia and the discontinuation of antipsychotic medications. Schizophr Bull 1997;23:3-9.
10. Wyatt RJ, Green MF, Tuma AH. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: A re-analysis of the Camarillo State Hospital data. Psychol Med 1997;27:261-8.
11. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of firste-pisode patients: A systematic review. Arch Gen Psychiatry 2005;62:975-83.
12. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: Initial results from the schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophr Bull 1998;24:11-20; discussion 20-32.
13. Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health 2002;92:92-8.
14. Glick ID. Understanding the results of CATIE in the context of the field. CNS Spectr 2006;11:40-7.
15. Lehman AF. Public health policy, community services, and outcomes for patients with schizophrenia. Psychiatr Clin North Am 1998;21:221-31.
16. Valenstein M, Ganoczy D, McCarthy JF, et al. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review. J Clin Psychiatry 2006; 67:1542-50.
17. Kikkert MJ, Schene AH, Koeter MW, et al. Medication adherence in schizophrenia: Exploring patients', carers' and professionals' views. Schizophr Bull 2006;32:786-94.
18. Deegan PE, Drake RE. Shared decision making and medication management in the recovery process. Psychiatr Serv 2006;57: 1636-9.
19. Loffler W, Kilian R, Toumi M, et al. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 2003;36:105-12.
20. Pound P, Britten N, Morgan M, et al. Resisting medicines: A synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61:133-55.
21. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophr Bull 1997;23:637-51.
22. Tam C, Law S. Best practices: A systematic approach to the management of patients who refuse medications in an assertive community treatment team setting. Psychiatr Serv 2007;58: 457-9.
23. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 1995; 11:443-55.
24. Donovan JL, Blake DR. Patient non-compliance: Deviance or reasoned decision-making? Soc Sci Med 1992;34:507-13.
25. Diamond RJ. Enhancing medication use in schizophrenic patients. J Clin Psychiatry 1983;44:7-14.
26. Corrigan PW, Liberman RP, Engel JD. From noncompliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry 1990;41:1203-11.
27. Frank E, Kupfer DJ, Siegel LR. Alliance not compliance: A philosophy of outpatient care. J Clin Psychiatry 1995;56:11-6; discussion 16-7.
28. Aquila R,Weiden PJ, Emanuel M. Compliance and the rehabilitation alliance. J Clin Psychiatry 1999;60:23-7; discussion 28-9.
29. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681-92.
30. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: Revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-61.
31. O'Connor AM, Wennberg JE, Legare F, et al. Toward the 'tipping point': Decision aids and informed patient choice. Health Aff (Millwood) 2007;26:716-25.
32. Towle A, Godolphin W. Framework for teaching and learning informed shared decision making. BMJ 1999;319:766-71.
33. Fraenkel L, McGraw S. What are the essential elements to enable patient participation in medical decision making? J Gen Intern Med 2007;22:614-9.
34. O'Connor AM, Bennett C, Stacey D, et al. Do patient decision aids meet effectiveness criteria of the International Patient Decision Aid Standards collaboration? A systematic review and meta-analysis. Med Decis Making 2007;27:554-74.
35. Elwyn G, O'Connor A, Stacey D, et al. on behalf of the International Patient Decision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process. BMJ 2006;333:417.
36. National Alliance on Mental Illness: Grading the states: A report on America's health care system for serious mental illness. Arlington VA: National Alliance on Mental Illness; 2006.
37. Coulter A. Supporting shared decision-making in the clinical setting: How should we assess the effects of patient decision aids. In: Modélisation de la relation patient-médecin et méthodes de rév́ elation des préférences des patients [Models of the patient-physician relationship and methods for eliciting patients' preferences] Atelier 114, April 20-21, 2000, La Londe les Maures.
38. Montori VM, Gafni AG, Charles CC. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: The case of diabetes. Health Expect 2006;9:25-36.
39. Harrington J, Noble LM, Newman SP. Improving patients' communication with doctors: A systematic review of intervention studies. Patient Educ Couns 2004;52:7-16.
40. Holmes-Rovner M, Gruman J, Rovner DR. Shared decision-making in the US: Research & development outpaces delivery. Z Arztl Fortbild Qualitatssich 2007;101:254-8.
41. Stewart MA. Effective physician-patient communication and health outcomes: A review. CMAJ 1995;152:1423-33.
42. Auerbach SM. Should patients have control over their own health care? Empirical evidence and research issues. Ann Behav Med 2000; 22:246-59.
43. Auerbach SM, Martelli MF, Mercuri LG. Anxiety, information, interpersonal impacts, and adjustment to a stressful health care situation. J Pers Soc Psychol 1983;44:1284-96.
44. Seeman M, Seeman TE. Health behavior and personal autonomy: A longitudinal study of the sense of control in illness. J Health Soc Behav 1983;24:144-60.
45. Frosch DL, Kaplan RM. Shared decision making in clinical medicine: Past research and future directions. Am J Prev Med 1999;17:285-94.
46. Evans RG, Edwards A, Evans S, et al. Assessing the practicing physician using patient surveys: A systematic review of instruments and feedback methods. Fam Pract 2007;24: 117-27.
47. Innes M, Skelton J, Greenfield S. A profile of communication in primary care physician telephone consultations: Application of the Roter interaction analysis system. Br J Gen Pract 2006;56:363-8.
48. Krupat E, Frankel R, Stein T, et al. The four habits coding scheme: Validation of an instrument to assess clinicians' communication behavior. Patient Educ Couns 2006; 62:38-45.
49. Manzoni GC, Torelli P. The patient-physician relationship in the approach to therapeutic management. Neurol Sci 2007;28: S130-3.
50. Rao JK, Anderson LA, Inui TS, et al. Communication interventions make a difference in conversations between physicians and patients: A systematic review of the evidence. Med Care 2007;45:340-9.
51. Scott A. Improving communication for better patient care. Radiol Technol 2007;78:205-18.
52. Wissow L. Self-monitoring and the not-yet-consciously patient-centered practitioner. Patient Educ Couns 2006;62: 1-2.
53. Loh A, Simon D,Wills CE, et al. The effects of a shared decision-making intervention in primary care of depression: A cluster-randomized controlled trial. Patient Educ Couns 2007;67: 324-32.
54. Bieber C, Muller KG, Blumenstiel K, et al. Long-term effects of a shared decision-making intervention on physician-patient interaction and outcome in fibromyalgia. A qualitative and quantitative 1 year follow-up of a randomized controlled trial. Patient Educ Couns 2006;63:357-66.
55. Joosten EA, DeFuentes-Merillas L, de Weert GH, et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008;77:219-26.
56. Von Korff M, Katon W, Rutter C, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med 2003;65:938-43.
57. Ludman E, Katon W, Bush T, et al. Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psychol Med 2003;33: 1061-70.
58. Malm U, Ivarsson B, Allebeck P, et al. Integrated care in schizophrenia: A two-year randomized controlled study of two community-based treatment programs. Acta Psychiatr Scand 2003;107:415-23.
59. Hamann J, Cohen R, Leucht S, et al. Shared decision making and long-term outcome in schizophrenia treatment. J Clin Psychiatry 2007;68:992-7.
60. O'Connor A, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screen decisions. Cochrane Database Syst Rev 2003;2:CD001431.
61. Laugharne R, Priebe S. Trust, choice and power in mental health. Soc Psychiatry Epidemiol 2006;41:843-52.
62. Swanson JW, Tepper MC, Backlar P, et al. Psychiatric advance directives: An alternative to coercive treatment? Psychiatry 2000;63:160-72.
63. Swanson JW, Swartz MS, Hannon MJ, et al. Psychiatric advanced directives: A survey of persons with schizophrenia, family members, and treatment providers. International Journal of Forensic Mental Health 2003;2:73-86 (available at www.iafmhs.org/files/Swansonspring03.pdf, accessed October 9, 2008).
64. Adams JR, Drake RE, Wolford GL. Shared decision-making preferences of people with severe mental illness. Psychiatr Serv 2007;58:1219-21.
65. Hamann J, Cohen R, Leucht S, et al. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry 2005;162:2382-4.
66. Bunn H, O'Connor A. Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res 1996;28:13-27.
67. Seale C, Chaplin R, Lelliott P, et al. Sharing decisions in consultations involving anti-psychotic medication: A qualitative study of psychiatrists' experiences. Soc Sci Med 2006;62: 2861-73.
68. Jones PB, Barnes TR, Davies L, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006;63:1079-87.
69. Newcomer JW. Metabolic considerations in the use of antipsychotic medications: A review of recent evidence. J Clin Psychiatry 2007;68:20-7.
70. Newcomer JW, Lieberman JA. Comparing safety and tolerability of antipsychotic treatment. J Clin Psychiatry 2007;68: e07.
71. Newcomer JW, Sernyak MJ. Identifying metabolic risks with antipsychotics and monitoring and management strategies. J Clin Psychiatry 2007;68:e17.
72. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23.
73. Haddad P, Dursun SM. Selecting antipsychotics in schizophrenia: Lessons from CATIE. J Psychopharmacol 2006;20: 332-4.
74. Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: Schizophrenia trial design and protocol development. Schizophr Bull 2003;29:15-31.
75. Perkins DO. Clinical trials in schizophrenia with results for the real world. CNS Spectr 2006;11:9-13.
76. Nasrallah HA. Introduction: Evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond. J Clin Psychiatry 2007;68:3-4.
77. Moffic HS. Ethical principles for psychiatric administrators: The challenge of formularies. Psychiatr Q 2006;77:319-27.
78. Meyer JM. Strategies for the long-term treatment of schizophrenia: Real-world lessons from the CATIE trial. J Clin Psychiatry 2007;68:28-33.
79. Salzer MS, Evans AC. CATIE and the value of atypical antipsychotics in the context of creating a recovery-oriented behavioral health system. Adm Policy Ment Health 2006;33: 536-40.
80. Glazer WM, Conley RR, Citrome L. Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study. CNS Spectr 2006;11:1-13.
81. Weiden PJ, Preskorn SH, Fahnestock PA, et al. Roadmap survey: Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: A roadmap. J Clin Psychiatry 2007;68:1-48.
82. Marder SR, Essock SM, Miller AL, et al. The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull 2002;28:5-16.
83. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, second edition. Arlington, VA: American Psychiatric Association; 2004 (available at www.psychiatryonline.com /pracGuide/pracGuideTopic-6.aspx, accessed October 14, 2008).
84. American Psychiatric Association. Treating schizophrenia: A quick reference guide (based on the 2004 guideline). Arlington, VA: American Psychiatric Association; 2004 (Available at at www.psychiatryonline.com/ pracGuide/loadPracQuickRefPdf.as px?file=Schizophrenia-QRG, accessed November 4, 2008).
85. Department of Veterans Affairs Pharmacy Benefits Management Strategic Healthcare Group, Medical Advisory Panel, and Mental Health Strategic Healthcare Group. Recommendations for atypical antipsychotic use in schizophrenia and schizoaffective disorders, June 2002; updated November 2003; updated May 2004; revised March 2007 (available at www.pbm.va.gov or http://vaww.pbm.va.gov, accessed October 14, 2008).
86. Department of Veterans Affairs, Veterans Health Administration. Shared decision making.Washington, DC: VHA Notice 99-02; June 15, 1999 (available at www1.va.gov/vhapublications/ViewPublication.asp?pub-ID=1081, accessed November 5, 2008).
87. Texas Department of State Health Services. Texas implementation of medication algorithms: Schizophrenia algorithm and clinician's manual (available at www.dshs.state.tx.us/mhprograms/TIMA.shtm, accessed October 14, 2008).
88. Miller AL, Chiles JA, Chiles JK, et al. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. J Clin Psychiatry 1999;60:649-57.
89. Chiles JA, Miller AL, Crismon ML, et al. The Texas Medication Algorithm Project: Development and implementation of the schizophrenia algorithm. Psychiatr Serv 1999;50: 69-74.
90. Gilbert DA, Altshuler KZ, Rago WV, et al. Texas medication algorithm project: Definitions, rationale, and methods to develop medication algorithms. J Clin Psychiatry 1998;59: 345-51.
91. Rush AJ, Rago WV, Crismon ML, et al. Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project. J Clin Psychiatry 1999;60: 284-91.
92. Shon SP, Crismon ML, Toprac MG, et al. Mental health care from the public perspective: The Texas Medication Algorithm Project. J Clin Psychiatry 1999;60:16-20; discussion 21.
93. Miller AL, Hall CS, Crismon ML, et al. TIMA procedural manual: Schizophrenia module. January 8, 2003.
94. Bruera E, Sweeney C, Calder K, et al. Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol 2001;19:2883-5.
95. Braddock CH 3rd, Edwards KA, Hasenberg NM, et al. Informed decision making in outpatient practice: Time to get back to basics. JAMA 1999;282:2313-20.
96. Rothenbacher D, Lutz MP, Porzsolt F. Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about it. Eur J Cancer 1997;33: 1184-9.
97. Makoul G, Arntson P, Schofield T. Health promotion in primary care: Physician-patient communication and decision making about prescription medications. Soc Sci Med 1995;41: 1241-54.
98. Stevenson FA, Barry CA, Britten N, et al. Doctor-patient communication about drugs: The evidence for shared decision making. Soc Sci Med 2000;50:829-40.
99. Samele C, Lawton-Smith S, Warner L, et al. Patient choice in psychiatry. Br J Psychiatry 2007;191:1-2.
100. Moumjid N, Gafni A, Bremond A, et al. Shared decision making in the medical encounter: Are we all talking about the same thing? Med Decis Making 2007;27:539-46.
101. Moumjid N, Bremond A, Carrere MO. From information to shared decision-making in medicine. Health Expect 2003;6: 187-8.
102. Charles C, Gafni A, Whelan T. Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expect 2004;7:338-48.
103. Charles C, Gafni A, Whelan T, et al. Cultural influences on the physician-patient encounter: The case of shared treatment decision-making. Patient Educ Couns 2006;63:262-7.
104. Stroup TS, Appelbaum PS. Evaluation of &subject advocate& procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study. Schizophr Bull 2006;32:147-52.
105. Lewin SA, Skea ZC, Entwistle V, et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2001;(4): CD003267.
106. Priebe S, McCabe R, Bullenkamp J, et al. Structured patient-clinician communication and 1-year outcome in community mental healthcare. Br J Psychiatry 2007;191:420-6.
107. Young AS, Mintz J, Cohen AN. Using information systems to improve care for persons with schizophrenia. Psychiatr Serv 2004;55:253-5.
108. Young AS, Mintz J, Cohen AN, et al. A network-based system to improve care for schizophrenia: The medical informatics network tool (MINT). J Am Med Inform Assoc 2004;11: 358-67.
109. Garb HN. Computer-administered interviews and rating scales. Psychol Assess 2007;19:4-13.
110. Moore HK, Mundt JC, Modell JG, et al. An examination of 26,168 Hamilton depression rating scale scores administered via interactive voice response across 17 randomized clinical trials. J Clin Psychopharmacol 2006;26:321-4.
111. Chinman M, Young AS, Schell T, et al. Computer-assisted self-assessment in persons with severe mental illness. J Clin Psychiatry 2004;65:1343-51.
112. Wolford G, Rosenberg SD, Rosenberg HJ, et al. A clinical trial comparing interviewer and computer-assisted assessment among clients with severe mental illness. Psychiatr Serv 2008;59:769-75.
113. Deegan PE. The lived experience of using psychiatric medication in the recovery process and a shared decision-making program to support it. Psychiatr Rehabil J 2007;31:62-9.
114. Deegan PE, Rapp C, Holter M, et al. Best practices: A program to support shared decision making in an outpatient psychiatric medication clinic. Psychiatr Serv 2008;59:603-5.
115. Carpenter WT Jr, Gold JM, Lahti AC, et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 2000;57:533-8.
116. Ganzini L, Volicer L, Nelson W, et al. Pitfalls in assessment of decision-making capacity. Psychosomatics 2003;44:237-43.
117. Ganzini L, Volicer L, Nelson WA, et al. Ten myths about decision-making capacity. J Am Med Dir Assoc 2005;6:S100-4.
118. Jeste DV, Depp CA, Palmer BW. Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: An overview. Schizophr Bull 2006;32:121-8.
119. Jeste DV, Dunn LB, Palmer BW, et al. A collaborative model for research on decisional capacity and informed consent in older patients with schizophrenia: Bioethics unit of a geriatric psychiatry intervention research center. Psychopharmacology (Berl) 2003;171:68-74.
120. Swanson JW, Swartz MS, Elbogen EB, et al. Facilitated psychiatric advance directives: A randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness. Am J Psychiatry 2006;163: 1943-51.
121. Kim MM, Van Dorn RA, Scheyett AM, et al. Understanding the personal and clinical utility of psychiatric advance directives: A qualitative perspective. Psychiatry 2007;70:19-29.
122. Scheyett AM, Kim MM, Swanson JW, et al. Psychiatric advance directives: A tool for consumer empowerment and recovery. Psychiatr Rehabil J 2007;31:70-5.
123. Swanson KA, Bastani R, Rubenstein LV, et al. Effect of mental health care and shared decision making on patient satisfaction in a community sample of patients with depression. Med Care Res Rev 2007;64:416-30.